Knockdown of AKT2 expression by RNA interference inhibits proliferation, enhances apoptosis, and increases chemosensitivity to the anticancer drug VM-26 in U87 glioma cells
暂无分享,去创建一个
C. Luo | Yi-cheng Lu | G. Hu | Yong Cui | Qi Wang | Junyu Wang | Yan Dong
[1] Feng-peng Wang,et al. H1, a derivative of Tetrandrine, exerts anti-MDR activity by initiating intrinsic apoptosis pathway and inhibiting the activation of Erk1/2 and Akt1/2. , 2011, Biochemical pharmacology.
[2] Hua He,et al. Candidate genes influencing sensitivity and resistance of human glioblastoma to Semustine , 2011, Brain Research Bulletin.
[3] Guoyou Zhang,et al. Knockdown of Akt Sensitizes Osteosarcoma Cells to Apoptosis Induced by Cisplatin Treatment , 2011, International journal of molecular sciences.
[4] Erwin G. Van Meir,et al. Exciting New Advances in Neuro‐Oncology: The Avenue to a Cure for Malignant Glioma , 2010, CA: a cancer journal for clinicians.
[5] R. Niu,et al. Reduction of Akt2 inhibits migration and invasion of glioma cells , 2009, International journal of cancer.
[6] J. Delattre,et al. Role of ABC transporters in the chemoresistance of human gliomas. , 2006, Current cancer drug targets.
[7] A. Toker,et al. Akt signaling and cancer: surviving but not moving on. , 2006, Cancer research.
[8] C. Marras,et al. Expression of Drug Resistance Proteins Pgp, MRP1, MRP3, MRP5 AND GST-π in Human Glioma , 2005, Journal of Neuro-Oncology.
[9] Wolfgang Löscher,et al. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases , 2005, Progress in Neurobiology.
[10] K. Aldape,et al. Expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Expression of Vascular Endothelial Growth Factor in and Angiogenic Phenotype of Human Gastric Cancer , 2005, Clinical Cancer Research.
[11] R. Grobholz,et al. Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer , 2003, International journal of cancer.
[12] S. Spiegl-Kreinecker,et al. Expression and Functional Activity of the ABC-transporter Proteins P-glycoprotein and Multidrug-resistance Protein 1 in Human Brain Tumor Cells and Astrocytes , 2002, Journal of Neuro-Oncology.
[13] H. Nakayama,et al. High expression levels of nuclear factor κB, IκB kinase α and Akt kinase in squamous cell carcinoma of the oral cavity , 2001 .
[14] J. Yamashita,et al. Expression of Multidrug Resistance-associated Protein (MRP) in Human Gliomas , 2000, Journal of Neuro-Oncology.
[15] T. Batchelor,et al. New treatment strategies for malignant gliomas. , 1999, The oncologist.
[16] Y. Rustum,et al. MDR1 P-glycoprotein is expressed by endothelial cells of newly formed capillaries in human gliomas but is not expressed in the neovasculature of other primary tumors. , 1996, The American journal of pathology.
[17] J. Cheng,et al. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. Cheng,et al. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas , 1995, International journal of cancer.
[19] J. Cheng,et al. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[20] M. Walker,et al. 4′‐Demethyl‐epipodophyllotoxin‐β‐D‐thenylidene‐glucoside (PTG) in the treatment of malignant intracranial neoplasms , 1974 .
[21] J. Cheng,et al. The Effects of Antisense AKT2 RNA on the Inhibition of Malignant Glioma Cell Growth in vitro and in vivo , 2005, Journal of Neuro-Oncology.
[22] M. Saji,et al. Carcinoma Overexpression and Overactivation of Akt in Thyroid Updated , 2001 .
[23] Jiayuh Lin,et al. Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis. , 2000, Anticancer research.